Sale!

ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test

Original price was: $700.Current price is: $500.

-29%

The ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the ATR gene associated with increased cancer susceptibility and cutaneous telangiectasia. This advanced next-generation sequencing test provides crucial insights into hereditary cancer predisposition, enabling proactive medical management and personalized screening protocols. The test detects specific genetic variants that significantly elevate risks for various cancers including breast, ovarian, and pancreatic malignancies. Individuals with family history of cancer, unexplained telangiectasia, or multiple primary cancers should consider this test. Benefits include early risk identification, personalized prevention strategies, and informed family planning decisions. The test costs $500 USD with a regular price of $700 USD, offering substantial savings for comprehensive genetic cancer risk assessment.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Cancer Risk

The ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This sophisticated diagnostic tool utilizes next-generation sequencing technology to analyze the ATR gene, which plays a critical role in DNA damage response and cellular repair mechanisms. Mutations in this gene are strongly associated with increased susceptibility to various cancers and the development of cutaneous telangiectasia – visible blood vessel abnormalities on the skin.

What This Advanced Genetic Test Measures

Our comprehensive NGS-based test specifically targets and sequences the entire ATR gene to identify pathogenic variants, including:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions (indels)
  • Copy number variations affecting gene function
  • Regulatory region abnormalities
  • Novel mutations with clinical significance

The test provides complete coverage of all coding regions and critical intronic boundaries, ensuring maximum detection sensitivity for clinically relevant variants associated with cancer predisposition syndromes.

Who Should Consider ATR Gene Testing?

Clinical Indications and Risk Factors

This genetic test is particularly recommended for individuals presenting with:

  • Personal history of multiple primary cancers
  • Early-onset cancer diagnoses (before age 50)
  • Family history of ATR-related cancer syndromes
  • Unexplained cutaneous telangiectasia development
  • Multiple family members with similar cancer types
  • Bilateral or multifocal cancer occurrences
  • Rare cancer types in personal or family history
  • Known ATR mutation in family members

Symptoms and Clinical Presentations

Patients may exhibit various clinical features including:

  • Visible spider-like blood vessels on skin surfaces
  • Increased sensitivity to sunlight and radiation
  • Premature aging signs in sun-exposed areas
  • Recurrent skin abnormalities and lesions
  • Neurological symptoms in some variant forms
  • Immunodeficiency manifestations
  • Developmental delays in childhood presentations

Significant Benefits of ATR Genetic Testing

Proactive Health Management Advantages

Undergoing ATR gene testing provides numerous critical benefits:

  • Early Risk Identification: Detect genetic predisposition before cancer development
  • Personalized Screening Protocols: Tailor cancer surveillance based on genetic risk
  • Informed Family Planning: Make reproductive decisions with complete genetic information
  • Preventive Interventions: Implement risk-reduction strategies proactively
  • Family Member Testing: Identify at-risk relatives for early intervention
  • Treatment Guidance: Inform therapeutic approaches for existing cancers
  • Psychological Relief: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Comprehensive Result Interpretation

Your genetic test results will fall into one of several categories with specific clinical implications:

  • Positive Result: Identification of a known pathogenic ATR mutation confirms increased cancer risk and necessitates enhanced surveillance and preventive measures
  • Negative Result: No detected mutation in an individual with family history of ATR mutations typically indicates baseline population cancer risk
  • Variant of Uncertain Significance (VUS): Identified genetic changes with unclear clinical impact require ongoing monitoring and family studies
  • Benign Variants: Common polymorphisms with no established disease association

All positive results include detailed clinical management recommendations and referral to genetic counseling services for comprehensive risk assessment and family communication strategies.

Test Details and Pricing

Test Parameter Details
Test Name ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Medical Specialty Dermatology, Genetics, Oncology

Pre-Test Requirements and Preparation

Essential Pre-Testing Protocol

To ensure accurate and meaningful results, the following preparations are required:

  • Complete clinical history documentation of the patient
  • Genetic counseling session with certified genetic counselor
  • Detailed pedigree chart creation documenting family cancer history
  • Informed consent process explaining test implications
  • Insurance pre-authorization when applicable
  • Discussion of potential psychological impacts

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t wait to gain crucial insights into your cancer risk profile. Our ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test provides the comprehensive genetic information needed for informed healthcare decisions. With our special discounted price of $500 USD (regularly $700 USD), this advanced testing is more accessible than ever.

Call us now at +1(267) 388-9828 to schedule your genetic counseling session and test appointment. Our dedicated genetic specialists are ready to guide you through the testing process and help you understand your results for better health outcomes.

Early detection through genetic testing can save lives. Take the first step toward personalized cancer prevention and management today.